February 1, 2023
February 2023 Provider Newsletter - New Hampshire
Administrative
CommercialMedicare AdvantageJanuary 31, 2023
AIM Specialty Health will transition to Carelon Medical Benefits Management Inc.CommercialMedicare AdvantageJanuary 31, 2023
Anthem Blue Cross and Blue Shield will begin reimbursing for services provided by unlicensed clinical behavioral health providers actively seeking licensure in New HampshireCommercialJanuary 31, 2023
Controlling High Blood Pressure and Submitting Compliant ReadingsCommercialJanuary 31, 2023
Have you reviewed your online provider directory information lately?CommercialJanuary 31, 2023
Do you offer telehealth services? Let us know!CommercialJanuary 31, 2023
Helping to reduce delays when submitting attachments: Make sure your correspondence includes one of these elementsCommercialMedicare AdvantageJanuary 31, 2023
Enhancing Provider News website and email communicationsCommercialMedicare AdvantageJanuary 31, 2023
Enhancing Provider News website and email communicationsPolicy Updates
CommercialJanuary 31, 2023
Medical Policy and Clinical Guideline updates are available on our provider websiteMedicare AdvantageJanuary 31, 2023
AIM Specialty Health Cardiology Clinical Appropriateness Guidelines CPT Code List updateCommercialMedicare AdvantageJanuary 31, 2023
Updates to AIM Specialty Health Advanced Imaging Clinical Appropriateness GuidelinesProducts & Programs
CommercialJanuary 31, 2023
2023 FEP benefit information available onlineCommercialJanuary 31, 2023
Specialty pharmacy updates - February 2023CommercialJanuary 31, 2023
Clinical Criteria updates for specialty pharmacyState & Federal
Medicare AdvantageJanuary 31, 2023
City of Manchester Offers Medicare Advantage Option - New HampshireMedicare AdvantageJanuary 31, 2023
Name change announcement: myNEXUS will transition to Carelon Post Acute Solutions on March 1, 2023Medicare AdvantageJanuary 31, 2023
Keep up with Medicare newsPlease continue to check Important Medicare Advantage Updates for the latest Medicare Advantage information, including:
- Anthem Blue Cross and Blue Shield expands specialty pharmacy precertification list (Fylnetra)
- Anthem Blue Cross and Blue Shield expands specialty pharmacy precertification list (Spevigo, Xenpozyme)
- Specialty pharmacy precertification list expansion (Rolvedon, Stimufend)
- New specialty pharmacy medical step therapy requirements
- Prior authorization requirement changes effective April 1, 2023
- Medical Policies and Clinical Utilization Management Guidelines update
To view this publication online:
Or scan this QR code with your phone